Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 12/20 | 0.57 |
| ▸ | LPL | P06858 | 11/20 | 0.57 |
| ▸ | P4HB | P07237 | 1/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.36 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | F11 | P03951 | 2/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.33 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.33 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.33 |
| ▸ | SNCA | P37840 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13299967 | 0.90 | LIPG (0.48) | LIPGLPLP4HBDGAT1F11 | |
| SCHEMBL2515552 | 0.89 | LIPG (0.46) | LIPGLPLP4HB | |
| SCHEMBL17014607 | 0.88 | LIPG (0.55) | LIPGLPLP4HBKEAP1NFE2L2 | |
| SCHEMBL21624614 | 0.85 | LIPG (0.74) | LIPGLPLP4HBKEAP1NFE2L2 | |
| SCHEMBL17701201 | 0.85 | LIPG (0.74) | LIPGLPLP4HBKEAP1NFE2L2 | |
| SCHEMBL21416280 | 0.83 | LIPG (0.77) | LIPGLPLP4HBKEAP1NFE2L2 | |
| SCHEMBL1509154 | 0.83 | LIPG (0.77) | LIPGLPLP4HBKEAP1NFE2L2 | |
| SCHEMBL9613217 | 0.83 | LIPG (0.54) | LIPGLPLP4HBSNCACA1 | |
| SCHEMBL12214091 | 0.83 | LIPG (0.43) | LIPGLPLP4HB | |
| SCHEMBL21304574 | 0.81 | LIPG (0.64) | LIPGLPLP4HBKEAP1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120168739-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | CANON KABUSHIKI KAISHA (JP) | 2012-07-05 | — | — | US | disclosed |
| US-20120168739-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | CANON KABUSHIKI KAISHA (JP) | 2012-07-05 | — | — | US | disclosed |
| US-8158835-B2 | Fluorene compound and organic electroluminescence device | CANON KABUSHIKI KAISHA (JP) | 2012-04-17 | — | — | US | disclosed |
| US-8158835-B2 | Fluorene compound and organic electroluminescence device | CANON KABUSHIKI KAISHA (JP) | 2012-04-17 | — | — | US | disclosed |
| US-20090200919-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | CANON KABUSHIKI KAISHA (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090200919-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | CANON KABUSHIKI KAISHA (JP) | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120168739-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | AFF1, LEF1, AFF2 | LIPG 2072/4885LPL 1917/4885P4HB 3833/4885 |
| US-20090200919-A1 | FLUORENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | AFF1, LEF1, AFF2 | LIPG 2072/4885LPL 1917/4885P4HB 3833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.